The DrugMonkey blogger, who apparently works for NIH or another US government agency, says that the method for deciding on the order in which authors are listed on papers needs to be revised. PIs are always last, leaving everyone who did the heavy lifting vying for the coveted first-author position, according to the post. DrugMonkey's proposal: let reviewers flag which parts of the paper are most important, and then assign authorship order based on who contributed to those key parts.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.